APPEND MEDICAL
Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system. The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growing segment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
APPEND MEDICAL
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device MHealth
Founded:
2015-01-01
Address:
Or Yehuda, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.appendmedical.com
Total Employee:
1+
Status:
Active
Contact:
+972-547-250-960
Email Addresses:
[email protected]
Total Funding:
11.75 M USD
Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles CrUX Top 50m CrUX Dataset
Similar Organizations
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Stel Life
Stel Life simplifies health device connectivity for patients, care teams, and device companies.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Telcare
Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.
Current Employees Featured
Founder
Investors List
Shoni Health Ventures
Shoni Health Ventures investment in Series A - Append Medical
ALIVE Israel HealthTech Fund
ALIVE Israel HealthTech Fund investment in Series A - Append Medical
Intellectual Ventures
Intellectual Ventures investment in Series A - Append Medical
MEDX Xelerator
MEDX Xelerator investment in Series A - Append Medical
Boston Scientific
Boston Scientific investment in Series A - Append Medical
Official Site Inspections
http://www.appendmedical.com Semrush global rank: 4.92 M Semrush visits lastest month: 1.74 K
- Host name: 145.223.37.44
- IP address: 145.223.37.44
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Append Medical"
Simple, Implant-Free Transcatheter LAA Elimination | Append
A novel transcatheter LAA occlusion—safe, fast, and effective. Minimizes stroke risk, eliminates DRT and PDL, and reduces reliance on blood thinners and anticoagulantsSee details»
Append Medical - Crunchbase Company Profile
Organization. Append Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact …See details»
Append Medical - LinkedIn
The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA elimination thus reducing the risk of stroke in patients with non-valvular atrial fibrillation.See details»
Append Medical Company Profile | Management and Employees …
Www.appendmedical.com Append Medical Profile and History Append Medical, founded in 2017, develops the Appligator - a tool designed to reduce stroke risk in AF patients by excluding the …See details»
Append Medical 2025 Company Profile: Valuation, Funding
Www.appendmedical.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 8 Ariel Sharon Street; Or Yehuda 6037606; IsraelSee details»
Append Medical Raises $4.35M in Initial Closing of …
Jul 6, 2023 Append Medical was founded in 2018 by Dr. Zachi Berger and is a portfolio company of the MEDX Xelerator, an Israeli medical device incubator. For more information visit www.appendmedical.com. Press Contact: Marjie …See details»
Append Medical Raises $4.35M in Initial Closing of Extended …
Based on the idea of Dr. Leonid Sternik from Sheba Medical Center, Append Medical is developing the Append system, the first device designed to completely close the LAA in a …See details»
Append Medical - Overview, News & Similar companies - ZoomInfo
Aug 4, 2021 www.appendmedical.com. Revenue <$5 Million. Industry Medical Devices & Equipment Manufacturing . Recent News & Media. Append Medical Raises $4.35M in Initial …See details»
Append Medical - 2025 Company Profile - Tracxn
Mar 11, 2025 Append Medical - Developer of a device for the left atrial appendage closure system. Raised a total funding of $11.7M over 2 rounds from 4 investors. Founded by Zachi …See details»
Append Medical - F6S
Appendmedical.com. About Append Medical. The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA closure thus reducing the risk of stroke in …See details»
APPEND MEDICAL LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for APPEND MEDICAL LTD of OR YEHUDA, Central District. Get the latest business insights from Dun & …See details»
Append Medical - Israeli Startup | Startup Nation Finder
Jun 26, 2020 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. …See details»
Append Medical (Israel) Funding: $11.8M - Medical Startups
6 days ago Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure...See details»
Append Medical Ltd - VentureRadar
Website: http://www.appendmedical.com. Develops advanced transcatheter Left Atrial Appendage (LAA) closure systems for improved cardiac safety and minimally invasive ...See details»
Append Medical - Company Profile & Staff Directory - ContactOut
The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA closure thus reducing the risk of stroke in patients with non-valvular atrial fibrillation. Its unique …See details»
Israeli medical device company Append Medical completes €6.2M …
Aug 4, 2021 Developer of a noninvasive implant solution for transcatheter Left Atrial Appendage (LAA) exclusion, Apend Medical has announced the completion of a €6.2 million ($7.4m) …See details»
Israeli Medtech Startup Append Medical Develops the Appligator
Aug 5, 2021 Append Medical is an Israeli medtech startup that has developed the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage (LAA) exclusion. …See details»
Append Medical completes transcatheter implant-free LAA …
Nov 12, 2020 Append Medical, developer of the Appligator implant-free left atrial appendage (LAA) occlusion device, today announced completion of its first pre-clinical chronic …See details»
Append Medical Raises $4.35M in Initial Closing of Extended …
Jul 6, 2023 For more information please visit www.appendmedical.com. Press Contact: Marjie Hadad General Manager Must Have Communications 011-972-54-536-5220 marjie@mhc-pr. …See details»
Append Medical Raises $4.35M for Left Atrial Appendage System
Jul 10, 2023 Append's Appligator is in development to be a next generation, left atrial appendage (LAA) Elimination System designed to completely close the LAA without metal …See details»